Clal Biotechnology Industries
Profile and portfolio
Clal Biotechnology Industries is the corporate venture arm of Clal Industries, a healthcare company. It is based in Tel Aviv, Israel. It invests at the seed stage. Sectors it names: biotech and life sciences, medical devices.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Seed |
| Sectors | Biotech and life sciences, Medical devices |
| Geography | North America, Middle East and Africa |
| Offices | Tel Aviv, Israel |
Sources: S1 Clal Biotechnology Industries: About.
Where it invests and who leads it
LeadersS2
- Avi FischerChief Executive Officer and Chairman of the BoardFind on LinkedInFirm page
- Arnon AharonMedical DirectorFind on LinkedInFirm page
- Liat NissanChief Financial OfficerFind on LinkedInFirm page
Key facts
About Clal Industries
Portfolio
The firm's portfolio page lists 8 companies.S3
Every company on the Clal Biotechnology Industries list
8 companies, as listed on the firm's own website: 7 listed, 1 exited.S3 Read the firm's list.
Listed 7
- Biokine
- Colospan
- Elicio Therapeutics
- FDNA
- MediWound
- Pi-Cardia
- Sight Diagnostics
Exited 1
- Cadent Therapeutics
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
| Company | Type | Acquirer or exchange | Source |
|---|---|---|---|
| Cadent Therapeutics | Acquisition | Novartis | S3 |
Official pages
Read the firm's own pages for current information.
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Clal Biotechnology Industries or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.